BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 7992497)

  • 1. [Magnetic resonance tomography (MRT) of the breast in problem patients].
    Brezina A; Schwaighofer BW
    Wien Klin Wochenschr; 1994; 106(18):584-9. PubMed ID: 7992497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamic imaging with magnetic resonance in the diagnosis of breast disease].
    Ercolani P; Giovagnoni A; Giuseppetti G; Baldassarre S; De Nigris E; Amici F
    Radiol Med; 1991 Oct; 82(4):422-6. PubMed ID: 1767046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnetic resonance tomography of the breast. The results of 253 examinations].
    Kaiser WA
    Dtsch Med Wochenschr; 1989 Sep; 114(36):1351-7. PubMed ID: 2776660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
    Klengel S; Hietschold V; Schreiber M; Köhler K
    Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
    Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
    Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MR mammography at 0.5 tesla. II. The capacity to differentiate malignant and benign lesions in MR mammography at 0.5 and 1.5 T].
    Kuhl CK; Kreft BP; Hauswirth A; Gieseke J; Elevelt A; Reiser M; Schild HH
    Rofo; 1995 Jun; 162(6):482-91. PubMed ID: 7605960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
    De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
    Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technics for the preoperative marking of nonpalpable breast lesions in MRT].
    Sittek H; Kessler M; Müller-Lisse U; Untch M; Bohmert H; Reiser M
    Rofo; 1996 Jul; 165(1):84-7. PubMed ID: 8765369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contrast media in MR mammography].
    Tontsch P; Bauer M; Birmelin G; von Landenberg E; Moeller TB; Raible G
    Aktuelle Radiol; 1997 Mar; 7(2):86-92. PubMed ID: 9172669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contrast medium behavior of epithelial skin tumors and tumor-like changes in high resolution magnetic resonance tomography].
    Mäurer J; Schlums D; Lissau G; Richter W; Knollmann FD; Langer R; Bier J; Felix R
    Bildgebung; 1996 Jun; 63(2):120-5. PubMed ID: 8756155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
    Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
    Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
    Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
    J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
    Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contrast enhancement of the nipple in nuclear magnetic resonance tomography of the breast with Gd-DTPA].
    Beck R; Heywang SH; Eiermann W; Permanetter W; Lissner J
    Digitale Bilddiagn; 1987 Dec; 7(4):167-9. PubMed ID: 3436118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast MRI artefacts: evaluation and solutions in 630 consecutive patients.
    Fiaschetti V; Pistolese CA; Funel V; Rascioni M; Claroni G; Della Gatta F; Cossu E; Perretta T; Simonetti G
    Clin Radiol; 2013 Nov; 68(11):e601-8. PubMed ID: 23916550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation.
    Fobben ES; Rubin CZ; Kalisher L; Dembner AG; Seltzer MH; Santoro EJ
    Radiology; 1995 Jul; 196(1):143-52. PubMed ID: 7784558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic magnetic resonance mammography of both breasts following local excision and radiotherapy for breast carcinoma.
    Murray AD; Redpath TW; Needham G; Gilbert FJ; Brookes JA; Eremin O
    Br J Radiol; 1996 Jul; 69(823):594-600. PubMed ID: 8696694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The feasibility of magnetic resonance tomography in the diagnosis of non-palpable breast tumors].
    Zapf S; Halbsguth A; Brunier A; Mitze M; Klemencic J; Wilhelm K
    Rofo; 1991 Jan; 154(1):106-10. PubMed ID: 1846678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.